Clinical Trial Update: Anti-hyperglycemic Effect of Short-term Arginyl-fructose Supplementation in Subjects With Pre-diabetes and Newly Diagnosed Type 2 Diabetes: Randomized, Double-blinded, Placebo-controlled Trial. [NA]

View source ↗

Summary

This trial assesses whether short-term arginyl-fructose supplementation has anti-hyperglycemic effects in individuals with prediabetes and newly diagnosed type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• Arginyl-fructose (arginyl-fructose)

Snippet

Sponsor: Yonsei University | Conditions: Pre-diabetes | NA | Status: COMPLETED